Press Releases
October 2, 2026
AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
October 1, 2026
AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield™ ECG Services
September 29, 2026
AIML Subsidiary NeuralCloud Enters Strategic Partnership with RKS Medical Technologies to Advance CardioYield™ Clinical Pilots
September 21, 2026
AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform
September 1, 2026
AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs
August 18, 2026
AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield™ Pilot
August 11, 2026
AI/ML Innovations’ Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification
June 23, 2026
AI/ML Innovations Inc. Announces Grant of U.S. Patent Expanding Protection for AI-Driven ECG Analysis
June 1, 2026
AIML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
March 31, 2026
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
March 27, 2026
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
March 25, 2026
AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
March 12, 2026
AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
February 24, 2026
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
February 12, 2026
AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
February 10, 2026
Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
January 28, 2026
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
January 20, 2026
AIML subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets
January 8, 2026
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield™ for AI-Powered Holter Analysis
January 7, 2026
AIML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
December 30, 2025
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
December 9, 2025
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield™ and Insight360™ into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
December 2, 2025
AIML subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield™ and Insight360™ for Elite Athlete Cardiac Performance Testing
November 26, 2025
AIML subsidiary NeuralCloud Signs Commercial Term Sheet with Equimetrics to Deploy MaxYield™ and CardioYield™ across Equine Cardiac Monitoring Platforms
November 24, 2025
AIML subsidiary Neural Cloud begins pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care
November 11, 2025
AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture
November 4, 2025
AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield™ in Jamaica
October 21, 2025
AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting
October 15, 2025
AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica
October 7, 2025
AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting
September 30, 2025
AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection
June 10, 2025
AIML Strengthens IP Portfolio with Provisional Patents for AI Driven ECG Signal Processing
June 3, 2025
AIML Subsidiary Neural Cloud Signs LOI with Circular Health to License MaxYield™ ECG Signal-Processing
May 20, 2025
AIML Establishes Medical Advisory Board to Drive AI Powered ECG Signal Processing Innovation
May 15, 2025
AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield™ Signal Enhancement Platform
May 5, 2025
AIML Innovations Appoints Political Strategist and Public Affairs Leader, Michael Diamond, to Board of Directors
April 25, 2025
AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus
January 28, 2025
Andrea Ruth Joins AI/ML Innovations as Head of Quality, Clinical, and Regulatory Affairs
January 23, 2025
AI/ML Innovations Inc. Appoints Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships
Earlier releases
February 21, 2025
ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
February 21, 2025
Annual General & Special Meeting to be held on Friday, February 21, 2025
February 21, 2025
NOTICE AND ACCESS NOTIFICATION TO SHAREHOLDERS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
January 27, 2025
AI/ML Innovations Inc. Appoints Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships
January 9, 2025
AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors
January 6, 2025
AI/ML Innovations Inc. Announces Appointment of Peter Kendall as President and Chief Commercialization Officer
December 24, 2024
AI/ML INNOVATIONS CLOSES ACQUISITION OF QUANTUM SCIENCES LTD.
December 11, 2024
AI/ML Innovations Inc. Completes Shares for Debt Arrangement
December 10, 2024
AI/ML INNOVATIONS TO ACQUIRE QUANTUM SCIENCES LTD.
December 3, 2024
AI/ML Innovations Inc. Announces New Chief Financial Officer and Corporate Secretary; Enters Debt Settlement Arrangement
November 26, 2024
AI/ML Innovations Inc. Announces Final Private Placement Closing
November 1, 2024
AI/ML Innovations Inc. Announces Initial Private Placement Closing
October 28, 2024
AI/ML Innovations Inc. Increases Proposed Private Placement
October 21, 2024
AI/ML Innovations Inc. Announces Proposed Private Placement
October 11, 2024
AI/ML Innovations Announces Board Resignation
October 10, 2024
AI/ML Innovations Inc. Announces Impairment of Investment
October 2, 2024
AI/ML Innovations Inc. Announces Revocation of MCTO
September 20, 2024
AI/ML Innovations Inc. Provides Second Status Update
September 6, 2024
AI/ML Innovations Inc. Provides Status Update
August 29, 2024
AI/ML Innovations Inc. Granted Management Cease Trade Order
August 23, 2024
AI/ML Innovations Inc. Completes Acquisition of Technology from Naiad Lab Inc.
August 23, 2024
AI/ML Innovations Inc. Announces Late Filing of Annual Financial Disclosure
August 19, 2024
AI/ML Innovations Inc. Announces Closing of Financing
August 15, 2024
AI/ML Innovations Inc. Announces Settlement of Debt with ThreeD Capital Inc.
August 9, 2024
AI/ML Innovations Inc. Announces Proposed Private Placement
July 17, 2024
AI/ML Innovations Inc. Announces Closing of Financing
July 9, 2024
AI/ML Innovations Inc. Announces Upcoming Webinar
July 2, 2024
AI/ML Innovations Inc. Announces First Closing of Financing
June 21, 2024
AI/ML Innovations Inc. Announces Proposed Private Placement
June 19, 2024
AI/ML Innovations Inc. Launches TheNeuralCloud.com, a Neural Net as a Service Platform
June 17, 2024
AI/ML Innovations Inc. Completes Acquisition of Technology from Naiad Lab Inc.
June 14, 2024
AI/ML Innovations Inc. Announces Shares for Debt Transaction
May 28, 2024
AI/ML Innovations Inc. Introduces “The Neural Net Store”
May 17, 2024
AI/ML Innovations Inc. Announces Agreement with Moonshot Inc.
May 16, 2024
AI/ML Innovations Inc. Introduces NeuralCloud Solutions Incorporated, its Newest Operating Subsidiary
May 6, 2024
AI/ML Innovations Inc. Introduces its Proprietary “Long ECG Neural Network”
May 2, 2024
AI/ML Innovations Inc. Enters Binding Letter of Intent to Acquire Strategic Neural Net Healthcare Assets
April 10, 2024
AI/ML Innovations Inc. Chosen for Healthcare Micro Payment Integration Utilizing TodaQ MicroPay Technology
April 4, 2024
AI/ML Innovations Inc. Announces Upcoming Townhall
April 2, 2024
TODAQ Micro C:AIML ThingyAI™ DoTalk™ Launch Micropayments and AI Conversational Checkout
March 13, 2024
AI/ML Innovations Inc.’s Health Gauge Unveils ‘The Pulse Guru’, its Second Advanced Neural Network Based Commercial Product
March 11, 2024
AI/ML Innovations Inc. Announces Settlement of Debt with ThreeD Capital Inc.
March 6, 2024
AI/ML Innovations Inc.’sHealth Gauge Launches "Follow Your Heart": A Revolutionary Non-Invasive Blood Pressure Measurement Solution
March 4, 2024
AI/ML Innovations Inc. Welcomes Esmat Naikyar as Interim Chief Product Officer to Drive Healthcare Innovation
February 27, 2024
AI/ML Innovations Inc.’s Health Gauge Seeking FDA Approval for its Patented Blood Pressure Measurement Technology
February 14, 2024
AI/ML Innovations Inc. Appoints Dr. David Cramb, Dean of the Faculty of Science at Toronto Metropolitan University, as Chair of the Company’s Inaugural Science and Product Advisory Board
February 8, 2024
AI/ML Innovations Inc. Presents A Fireside Chat and a Company Update
February 6, 2024
AI/ML Innovations Inc. Unveils Micropayment Pilot Program in Collaboration with TODAQ Micro and Health Gauge Biometrics
January 23, 2024
AI/ML Innovations Inc.’s Subsidiary, Health Gauge, Unveils Its Proprietary “The Pulse Whisperer” for Biometric Raw Signal Data to Empower Life Science Researchers
January 17, 2024
AI/ML Innovations Inc.’s Subsidiary, Health Gauge, and Cornerstone Physiotherapy Partner to Implement Canada's First Telehealth Program for Long Covid Rehabilitation Enabled by Advanced Biometrics
January 12, 2024
AI/ML Innovations Inc. Announces Settlement of Debt with Octagon Media Inc.
January 9, 2024
AI/ML Innovations Inc. Announces Upcoming Townhall
December 18, 2023
AI/ML Innovations Inc. Closes Private Placement
December 11, 2023
AI/ML Innovations Inc. Terminates Investor Relations Appointment
December 8, 2023
AI/ML Innovations Inc. Enters Market Awareness Agreement
December 8, 2023
AI/ML Innovations Inc. Enters Market Awareness Agreement
December 7, 2023
AI/ML Innovations Inc. Announces Closing of Private Placement
December 1, 2023
AI/ML Innovations Inc. Grants Stock Options
November 21, 2023
AI/ML Innovations Inc. Announces Annual General Meeting Results
November 9, 2023
AI/ML Innovations Inc.’s Subsidiary Announces Strategic Partnership with a Leader in Virtual Occupational Health Clinics
November 1, 2023
AI/ML Innovations Inc., Advancing AI+AR Smart Glasses for Trillion Dollar Global Healthcare Markets
October 19, 2023
AI/ML Innovations Inc.’s Subsidiary Enters Consortium with Essilor International for AI-powered Augmented Reality Eyewear Project
October 11, 2023
AI/ML Innovations Inc. Announces Settlement of Debt
October 4, 2023
AI/ML Innovations Inc.’s Subsidiary Receives Funding Grant for Its Participation in Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly
September 29, 2023
NEWS RELEASE – for immediate release
September 21, 2023
AI/ML Innovations Inc. Announces Change to Board of Directors
September 11, 2023
Industry Expert Paul Duffy Takes the Helm as CEO of AI/ML Innovations Inc.
August 18, 2023
AI/ML Innovations Inc. Announces Option Grant and IR Agreement Restructuring
August 3, 2023
AI/ML Innovations AI-Powered Digital Health Platform Accelerating Momentum in Global Markets
July 31, 2023
AI/ML Innovations Inc. Announces Investor Relations Appointment
July 12, 2023
AI/ML Innovations Inc’s Subsidiary Revolutionizes Digital Health Platforms with AI Automation Enhancements
July 12, 2023
AI/ML Innovations Inc. Closes Oversubscribed Private Placement
July 7, 2023
AI/ML Innovations Inc. Announces Closing of Proposed Private Placement
June 30, 2023
AI/ML Innovations Inc. Announces Closing of Second Tranche of Private Placement
June 16, 2023
AI/ML Innovations Inc. Announces Proposed Private Placement
June 14, 2023
AI/ML Innovations’ AI-driven, Patented Technology is Chosen for University of Alberta Respiratory Disease Clinical Study
June 13, 2023
AI/ML Innovations Inc. Updates Closing of First Tranche of Private Placement
June 6, 2023
AI/ML Innovations Inc. Announces Closing of First Tranche of Proposed Private Placement
May 26, 2023
AI/ML Innovations Inc. Announces Strategic Agreement with World Weight Loss, Inc. to Develop an AI-powered Weight Loss Avatar and App
April 28, 2023
AI/ML Innovations Inc. Announces Interim CFO
April 11, 2023
AI/ML Innovations Introduces “Health Coach” - a Personalized AI- powered Health Advisor
March 28, 2023
AI/ML Innovations’ Tech2Heal Chosen for Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly
March 22, 2023
AI/ML Innovations Engages Frontier Flex Marketing for Market Awareness and Grants Stock Options
March 15, 2023
AI/ML Innovations Inc. Announces Update to Closing of Financing
March 14, 2023
AI/ML Innovations Inc. Announces Closing of Financing
March 6, 2023
AI/ML Innovations’ Health Gauge Concludes Successful Blood Pressure Validation Study on its AI-Powered Health Monitoring Solution
February 2, 2023
AI/ML Innovations’ Tech2Heal Wins Prestigious Innovation Grand Prize Award
January 24, 2023
AI/ML Innovations Inc. Announces Successful Closing of the Warrant Repricing and Early Warrant Exercise Incentive Program
January 12, 2023
AI/ML Innovations’ Tech2Heal Launches Its Remote Patient Care Platform
January 12, 2023
AI/ML Innovations Inc. Announces Successful Closing of the Warrant Repricing and Early Warrant Exercise Incentive Program
January 4, 2023
AI/ML Innovations’ Health Gauge to Investigate Potential Patent Infringement Enforcement
December 29, 2022
AI/ML Innovations Engages Octagon Media/Wall Street Reporter for Market Awareness
December 16, 2022
AI/ML Innovations Inc. Announces Warrant Repricing and Early Warrant Exercise Incentive Program
November 14, 2022
AI/ML INNOVATIONS ACQUIRES FULL OWNERSHIP OF DIGITAL HEALTHCARE COMPANY, HEALTH GAUGE INC.
November 4, 2022
AI/ML Innovations Inc. Announces Revocation of MCTO
October 25, 2022
AI/ML Innovations Inc. Provides Fourth Status Update
October 11, 2022
AI/ML Innovations Inc. Provides Third Status Update
September 27, 2022
AI/ML Innovations Inc. Provides Second Status Update
September 13, 2022
AI/ML Innovations Inc. Provides Status Update
August 30, 2022
AI/ML Innovations Inc. Granted Management Cease Trade Order